Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Award Notice opportunity from Department Of Defense was posted on August 31, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOL

Awarded
SPE2DP26F9320Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The Defense Logistics Agency, specifically the DLA Troop Support Medical Supply Chain, issued award SPE2DP26F9320 on August 31, 2026, to DMS Pharmaceutical Group Inc. This delivery order, placed under the base administrative contract SPE2DX25D9900, is for the procurement of Lidocaine Hydrochloride Oral Topical Solution, identified by NSN 6505000636197. The contract falls under NAICS code 325412 and is managed by the Department of Defense. The order specifies the delivery of 389 bottles at a unit price of 6.78, resulting in a total contract price of 74.58. The required delivery date for these supplies is September 15, 2026. This action is part of a broader administrative framework that replaces previous contract SPE2DX25D9383 and incorporates standard FAR clauses, including 52.222-50.

General Info

DLA awarded DMS Pharmaceutical Group $74.58 for 389 bottles of Lidocaine Hydrochloride.

Contract Value

$74.58

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

Not specified

Set-Aside

NONE

Award Issued Date

Documents

2
PDF, High priority: read this firstaward
High
PDF, Low prioritytask-order-award
Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP26F9320 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $74.58 Award Date: 08-31-2026 Delivery order under: SPE2DX25D9900 Line items: - LIDOCAINE HYDROCHLORIDE ORAL TOPICAL SOL (NSN/Part 6505000636197, PR 7018128242)

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS